ADMA Biologics Inc (NASDAQ:ADMA)
| 2.40 Delayed Data As of Sep 18 |  -0.015 / -0.62%Today’s Change | 1.45 Today|||52-Week Range 5.45 | -40.12% Year-to-Date |
Latest ADMA News | Press Releases
| Adma Biologics up 10% on launch of COVID-19 test Sep 03 / Seeking Alpha - Paid Partner Content | IBIO, SHLL, SRNE and NAK among midday movers Aug 24 / Seeking Alpha - Paid Partner Content |
| NVAX, WLL among premarket gainers Sep 03 / Seeking Alpha - Paid Partner Content | RIG, RKT among premarket gainers Aug 24 / Seeking Alpha - Paid Partner Content |
| NIH begs to differ on FDA's EUA for convalescent plasma for COVID-19 Sep 01 / Seeking Alpha - Paid Partner Content | Convalescent plasma players rally on FDA emergency use nod Aug 24 / Seeking Alpha - Paid Partner Content |
| FDA to fast-track COVID-19 vaccine - Financial Times Aug 31 / Seeking Alpha - Paid Partner Content | ADMA Biologics Is A Bargain Again After Recent Sell-Off Aug 23 / Seeking Alpha - Paid Partner Content |
| Does convalescent plasma help COVID-19 patients? Studies will answer Aug 29 / Seeking Alpha - Paid Partner Content | FDA allows emergency use of convalescent plasma to treat COVID-19 Aug 23 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 2.41 |
| Today’s open | 2.40 |
| Day’s range | 2.35 - 2.44 |
| Volume | 126,088 |
| Average volume (3 months) | 5,111,390 |
| Market cap | $193.4M |
Data as of 3:59pm ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | +38.94% |
| Earnings growth (this year) | +8.85% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +72.79% |
| P/E ratio | NM |
| Price/Sales | 7.41 |
| Price/Book | 5.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DYAIDyadic International... | +0.26 | +3.35% |
| MREOMereo BioPharma Grou... | -0.02 | -0.67% |
| AQBAquaBounty Technolog... | +0.67 | +14.89% |
| ALPNAlpine Immune Scienc... | +0.37 | +4.44% |
Data as of 3:59pm ET, 09/18/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $29.3M |
| Annual profit (last year) | -$48.3M |
| Net profit margin | -164.50% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Ramsey, New Jersey |
Forecasts
